BeOne Medicines Receives FDA Approval for TEVIMBRA Combination in First-Line HER2-Positive Gastroesophageal Cancer BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA)…
McKesson to Acquire Precision Medicine Group for Approximately $2.25 Billion to Expand Oncology and Biopharma Services McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire Precision Medicine Group,…
Lōkahi Therapeutics Begins GMP Manufacturing of LT-100 for Potential Osteoarthritis Pain Treatment Lōkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), has announced the initiation of its initial Good…
Catalent Completes $4.7 Billion Debt Refinancing to Strengthen Financial Position and Support Long-Term Growth Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and healthcare…
Vyome Holdings Reports Second-Quarter 2026 Results and Highlights Progress Across Clinical Pipeline Vyome Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for immuno-inflammatory and rare diseases, has announced…
Axoft Introduces Fleuron WISE Elastomer to Enable High-Resolution Imaging in Aqueous Environments Axoft, a neurotechnology company developing advanced materials and technologies for applications at the intersection of biology and electronics,…
Pretzel Therapeutics Receives FDA Clearance to Advance PX578 Into Phase 2 Study for POLG-Mediated Mitochondrial Disease Pretzel Therapeutics, Inc., a clinical-stage biotechnology company focused on developing a new generation of…
Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology Summit Therapeutics Inc. has announced the publication of primary analysis results from its global Phase III HARMONi clinical…
Copia Scientific and HSE•AG Partner to Expand On-Deck Nucleic Acid Quantification for Laboratory Automation Copia Scientific, a provider of laboratory automation, equipment, integration and technical service solutions, has announced a…
GeneDx Study Shows Hospital-Wide Rapid Genome Sequencing Can Improve Pediatric Diagnosis, Outcomes and Health System Efficiency GeneDx (Nasdaq: WGS), a company focused on rare disease diagnosis and the use of…
Spruce Biosciences Advances Toward 2026 BLA Submission for Tralesinidase Alfa in Sanfilippo Syndrome Type B Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies for…
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer to Advance Clinical Development Pipeline AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics through…